Quanterix Stock Price, News & Analysis (NASDAQ:QTRX)

$22.43 -0.96 (-4.10 %)
(As of 02/21/2018 02:54 PM ET)
Previous Close$22.43
Today's Range$22.23 - $23.70
52-Week Range$15.56 - $24.81
Volume110,400 shs
Average Volume118,815 shs
Market Capitalization$510.39 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Quanterix (NASDAQ:QTRX)

Quanterix logoQuanterix Corporation is a United States-based company, which develops tools for high definition diagnostics. The Company offers single molecule array (Simoa) platform, which uses single molecule measurements to access proteins. Simoa focuses on research and clinical testing applications. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology. The Company offers Simoa HD-1 analyzer, which creates high density arrays of approximately 40 femtoliter microwells. Its Simoa HD-1 analyzer is an automated immunoassay platform with multiplexing and custom assay capability. The Company offers Simoa consumables, which include Simoa Discs, Simoa Cuvettes, Simoa Sealing Oil, Simoa Buffers and Disposable Tips. It offers a range of complete assay kits, including multiplex panels, covering a range of therapeutic areas. Its services include Simoa Accelerator Lab and custom assay development services.

Receive QTRX News and Ratings via Email

Sign-up to receive the latest news and ratings for QTRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:QTRX
CUSIPN/A
Phone617-301-9400

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$17.58 million
Price / Sales27.84
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees122
Outstanding Shares21,820,000

Quanterix (NASDAQ:QTRX) Frequently Asked Questions

What is Quanterix's stock symbol?

Quanterix trades on the NASDAQ under the ticker symbol "QTRX."

Where is Quanterix's stock going? Where will Quanterix's stock price be in 2018?

4 equities research analysts have issued twelve-month price objectives for Quanterix's stock. Their forecasts range from $26.00 to $27.00. On average, they expect Quanterix's share price to reach $26.50 in the next twelve months. View Analyst Ratings for Quanterix.

Who are some of Quanterix's key competitors?

Who are Quanterix's key executives?

Quanterix's management team includes the folowing people:

  • Kevin Hrusovsky, Executive Chairman of the Board, President, Chief Executive Officer
  • Joseph S. Driscoll, Chief Financial Officer
  • David C. Duffy Ph.D., Senior Vice President, Research & Development and Chief Technology Officer
  • Ernest Orticerio, Senior Vice President - Finance and Corporate Development
  • Mark T. Roskey Ph.D., Senior Vice President and General Manager of Applications and Reagents
  • Bruce J. Bal, Vice President - Operations, Service and Quality
  • Douglas G. Cole M.D., Independent Director
  • John M. Connolly, Independent Director
  • Keith L. Crandell, Independent Director
  • Marijn E. Dekkers Ph.D., Independent Director

When did Quanterix IPO?

(QTRX) raised $50 million in an initial public offering on Thursday, December 7th 2017. The company issued 3,300,000 shares at a price of $14.00-$16.00 per share. J.P. Morga and Leerink Partners acted as the underwriters for the IPO and BTIG and Evercore ISI were co-managers.

When did the company's quiet period expire?

Quanterix's quiet period expired on Tuesday, January 16th. Quanterix had issued 4,275,200 shares in its initial public offering on December 7th. The total size of the offering was $64,128,000 based on an initial share price of $15.00. During the company's quiet period, insiders and any underwriters involved in the IPO were prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Who owns Quanterix stock?

Quanterix's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Flagship Pioneering Inc. (9.31%), Millennium Management LLC (2.35%), Jennison Associates LLC (1.36%), Park West Asset Management LLC (1.02%), Royce & Associates LP (0.94%) and Monashee Investment Management LLC (0.81%). Company insiders that own Quanterix stock include David R Walt, E Kevin Hrusovsky and Venture Fund Viii Overage Arch. View Institutional Ownership Trends for Quanterix.

Who bought Quanterix stock? Who is buying Quanterix stock?

Quanterix's stock was purchased by a variety of institutional investors in the last quarter, including Flagship Pioneering Inc., Millennium Management LLC, Jennison Associates LLC, Park West Asset Management LLC, Royce & Associates LP, Monashee Investment Management LLC, Platinum Investment Management Ltd. and Perceptive Advisors LLC. Company insiders that have bought Quanterix stock in the last two years include David R Walt, E Kevin Hrusovsky and Venture Fund Viii Overage Arch. View Insider Buying and Selling for Quanterix.

How do I buy Quanterix stock?

Shares of Quanterix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Quanterix's stock price today?

One share of Quanterix stock can currently be purchased for approximately $22.43.

How big of a company is Quanterix?

Quanterix has a market capitalization of $510.39 million and generates $17.58 million in revenue each year. Quanterix employs 122 workers across the globe.

How can I contact Quanterix?

Quanterix's mailing address is 113 HARTWELL AVE, LEXINGTON MA, 02421. The company can be reached via phone at 617-301-9400.


MarketBeat Community Rating for Quanterix (QTRX)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  24 (Vote Outperform)
Underperform Votes:  26 (Vote Underperform)
Total Votes:  50
MarketBeat's community ratings are surveys of what our community members think about Quanterix and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Quanterix (NASDAQ:QTRX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyN/AN/A
Consensus Rating Score: 3.003.00N/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $26.50$26.50N/AN/A
Price Target Upside: 23.43% upside23.43% upsideN/AN/A

Quanterix (NASDAQ:QTRX) Consensus Price Target History

Price Target History for Quanterix (NASDAQ:QTRX)

Quanterix (NASDAQ:QTRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/2/2018Leerink SwannInitiated CoverageOutperform -> Outperform$27.00HighView Rating Details
1/2/2018BTIG ResearchInitiated CoverageBuy$26.00HighView Rating Details
1/2/2018CowenInitiated CoverageOutperformHighView Rating Details
1/2/2018JPMorgan Chase & Co.Initiated CoverageOverweight -> OverweightHighView Rating Details
(Data available from 2/21/2016 forward)

Earnings

Earnings History for Quanterix (NASDAQ:QTRX)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Quanterix (NASDAQ:QTRX) Earnings Estimates

2018 EPS Consensus Estimate: ($0.90)
2019 EPS Consensus Estimate: ($0.31)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.23)($0.23)($0.23)
Q2 20181($0.22)($0.22)($0.22)
Q3 20181($0.23)($0.23)($0.23)
Q4 20181($0.22)($0.22)($0.22)
Q1 20191($0.17)($0.17)($0.17)
Q2 20191($0.10)($0.10)($0.10)
Q3 20191($0.05)($0.05)($0.05)
Q4 20191$0.01$0.01$0.01
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Quanterix (NASDAQ:QTRX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Quanterix (NASDAQ QTRX) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 8.95%
Insider Trades by Quarter for Quanterix (NASDAQ:QTRX)
Insider Trades by Quarter for Quanterix (NASDAQ:QTRX)

Quanterix (NASDAQ QTRX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/11/2017David R WaltDirectorBuy200,000$15.00$3,000,000.00View SEC Filing  
12/11/2017E Kevin HrusovskyInsiderBuy34,000$15.00$510,000.00View SEC Filing  
12/11/2017Venture Fund Viii Overage ArchMajor ShareholderBuy266,000$15.00$3,990,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Quanterix (NASDAQ QTRX) News Headlines

Source:
DateHeadline
 Quanterix Corp (QTRX) Given Consensus Recommendation of "Strong Buy" by Analysts Quanterix Corp (QTRX) Given Consensus Recommendation of "Strong Buy" by Analysts
www.americanbankingnews.com - February 16 at 9:28 PM
Quanterix (QTRX) Presents At Leerink Partners 7th Annual Global Healthcare Conference - SlideshowQuanterix (QTRX) Presents At Leerink Partners 7th Annual Global Healthcare Conference - Slideshow
seekingalpha.com - February 16 at 3:51 PM
Quanterix to Present at The LEERINK Partners 7th Annual Global Healthcare ConferenceQuanterix to Present at The LEERINK Partners 7th Annual Global Healthcare Conference
finance.yahoo.com - February 8 at 4:58 PM
$6.54 Million in Sales Expected for Quanterix Corp (QTRX) This Quarter$6.54 Million in Sales Expected for Quanterix Corp (QTRX) This Quarter
www.americanbankingnews.com - February 7 at 6:36 AM
-$0.30 EPS Expected for Quanterix Corp (QTRX) This Quarter-$0.30 EPS Expected for Quanterix Corp (QTRX) This Quarter
www.americanbankingnews.com - February 5 at 11:18 AM
 Quanterix Corp (QTRX) Given $25.67 Consensus Price Target by Brokerages Quanterix Corp (QTRX) Given $25.67 Consensus Price Target by Brokerages
www.americanbankingnews.com - January 31 at 7:20 PM
 Quanterix Corp (QTRX) Given Average Recommendation of "Strong Buy" by Brokerages Quanterix Corp (QTRX) Given Average Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - January 28 at 9:30 PM
Zacks: Quanterix Corp (QTRX) Given $25.67 Consensus Price Target by BrokeragesZacks: Quanterix Corp (QTRX) Given $25.67 Consensus Price Target by Brokerages
www.americanbankingnews.com - January 25 at 11:41 AM
Quanterix Uses JPMorgan Healthcare Conference to Scout Sales CandidatesQuanterix Uses JPMorgan Healthcare Conference to Scout Sales Candidates
finance.yahoo.com - January 23 at 9:04 AM
Zacks: Brokerages Anticipate Quanterix Corp (QTRX) Will Post Quarterly Sales of $6.54 MillionZacks: Brokerages Anticipate Quanterix Corp (QTRX) Will Post Quarterly Sales of $6.54 Million
www.americanbankingnews.com - January 21 at 6:44 AM
Zacks: Quanterix Corp (QTRX) Given Average Recommendation of "Strong Buy" by AnalystsZacks: Quanterix Corp (QTRX) Given Average Recommendation of "Strong Buy" by Analysts
www.americanbankingnews.com - January 20 at 9:36 PM
Head-To-Head Review: PAREXEL International (PRXL) versus Quanterix (QTRX)Head-To-Head Review: PAREXEL International (PRXL) versus Quanterix (QTRX)
www.americanbankingnews.com - January 13 at 9:26 AM
Quanterix Corps Quiet Period Set To End  on January 16th (NASDAQ:QTRX)Quanterix Corp's Quiet Period Set To End on January 16th (NASDAQ:QTRX)
www.americanbankingnews.com - January 9 at 1:22 AM
 Quanterix Corp (QTRX) Given $25.67 Average Target Price by Analysts Quanterix Corp (QTRX) Given $25.67 Average Target Price by Analysts
www.americanbankingnews.com - January 5 at 7:26 PM
Quanterix Corporation to Present at 36th Annual J.P. Morgan Healthcare ConferenceQuanterix Corporation to Present at 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 6:29 PM
Leerink Swann Weighs in on Quanterix Corps FY2017 Earnings (QTRX)Leerink Swann Weighs in on Quanterix Corp's FY2017 Earnings (QTRX)
www.americanbankingnews.com - January 4 at 6:04 AM
Critical Comparison: Quanterix (QTRX) versus Its PeersCritical Comparison: Quanterix (QTRX) versus Its Peers
www.americanbankingnews.com - January 3 at 9:44 PM
Quanterix Announces Commercial Availability of New SR-X Ultra-Sensitive Biomarker Detection System™Quanterix Announces Commercial Availability of New SR-X Ultra-Sensitive Biomarker Detection System™
finance.yahoo.com - January 3 at 7:10 AM
The Week Ahead: New Year Still Presents Some Earnings And Other CatalystsThe Week Ahead: New Year Still Presents Some Earnings And Other Catalysts
feeds.benzinga.com - January 2 at 1:36 PM
Quanterix Corp (QTRX) EC, President & CEO E Kevin Hrusovsky Bought $510,000 of SharesQuanterix Corp (QTRX) EC, President & CEO E Kevin Hrusovsky Bought $510,000 of Shares
finance.yahoo.com - December 13 at 6:42 PM
Quanterix Corp (QTRX) Insider E Kevin Hrusovsky Acquires 34,000 SharesQuanterix Corp (QTRX) Insider E Kevin Hrusovsky Acquires 34,000 Shares
www.americanbankingnews.com - December 13 at 5:46 PM
Insider Buying: Quanterix Corp (QTRX) Major Shareholder Buys 266,000 Shares of StockInsider Buying: Quanterix Corp (QTRX) Major Shareholder Buys 266,000 Shares of Stock
www.americanbankingnews.com - December 13 at 5:26 PM
Quanterix Corp (QTRX) Director David R. Walt Buys 200,000 SharesQuanterix Corp (QTRX) Director David R. Walt Buys 200,000 Shares
www.americanbankingnews.com - December 13 at 5:26 PM
Protein detection test company Quanterix prices upsized IPO at $15 midpointProtein detection test company Quanterix prices upsized IPO at $15 midpoint
www.nasdaq.com - December 7 at 7:12 PM
Quanterix (QTRX) IPO Opens 8% HigherQuanterix (QTRX) IPO Opens 8% Higher
www.streetinsider.com - December 7 at 7:12 PM
[$$] Quanterix Continues String of Life Sciences IPOs[$$] Quanterix Continues String of Life Sciences IPOs
finance.yahoo.com - December 7 at 7:12 PM
Quanterix Corp. (QTRX) Prices 4.275M Share IPO at $15/ShQuanterix Corp. (QTRX) Prices 4.275M Share IPO at $15/Sh
www.streetinsider.com - December 7 at 8:04 AM
Quanterix Gears Up for IPOQuanterix Gears Up for IPO
247wallst.com - December 6 at 8:04 AM
Quanterix Closes in on IPOQuanterix Closes in on IPO
247wallst.com - November 29 at 11:33 AM
Quanterix Plans $50 Million IPO for December 7th (QTRX)Quanterix Plans $50 Million IPO for December 7th (QTRX)
www.americanbankingnews.com - November 29 at 1:34 AM

SEC Filings

Quanterix (NASDAQ:QTRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Quanterix (NASDAQ QTRX) Stock Chart for Wednesday, February, 21, 2018

Loading chart…

This page was last updated on 2/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.